AbbVie Inc. (32)

Browse by Contract Category

Contracts

Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2021)
Registration Rights Agreement, dated May 14, 2020, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., BNP Paribas Securities... (Filed With SEC on May 14, 2020)
Agency Agreement, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC, U.K. Branch,... (Filed With SEC on May 14, 2020)
AbbVie 2013 Incentive Stock Program Second Amendment (Filed With SEC on August 5, 2019)
Supplemental Indenture No. 9, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC,... (Filed With SEC on May 14, 2020)
Supplemental Indenture No. 8, dated May 14, 2020, by and between AbbVie Inc. and U.S. Bank National Association, as trustee (Filed With SEC on May 14, 2020)
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 8, 2020)
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 8, 2020)
Amendment to the Transaction Agreement, dated as of May 5, 2020, between AbbVie Inc., Allergan plc and Venice Subsidiary, LLC (Filed With SEC on May 8, 2020)
Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 8, 2020)
Form of AbbVie Inc. Retention RSU Agreement - Ratable Vesting (Filed With SEC on May 8, 2020)
Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 8, 2020)
AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on May 8, 2020)
Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 21, 2020)
Purchase Agreement, dated November 12, 2019, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Barclays Capital Inc. (acting for themselves and as... (Filed With SEC on November 13, 2019)
AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on November 6, 2019)
Supplemental Indenture No. 6, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services... (Filed With SEC on September 26, 2019)
Agency Agreement, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC, UK... (Filed With SEC on September 26, 2019)
Underwriting Agreement, dated September 17, 2019, among AbbVie Inc. and Morgan Stanley & Co. International plc, HSBC Bank plc and Merrill Lynch International (acting for... (Filed With SEC on September 23, 2019)
Amended and Restated Revolving Credit Agreement, dated as of August 27, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on August 30, 2019)
AbbVie Supplemental Pension Plan, as amended and restated (Filed With SEC on August 5, 2019)
364-Day Term Loan Credit Agreement, dated as of July 12, 2019, among AbbVie, certain lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (Filed With SEC on July 16, 2019)
First Amendment to Revolving Credit Agreement, dated as of July 12, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on July 16, 2019)
364-Day Bridge Credit Agreement, dated as of June 25, 2019, among AbbVie, Morgan Stanley Senior Funding, Inc. and the lenders party thereto (Filed With SEC on June 25, 2019)
Transaction Agreement, dated as of June 25, 2019, between AbbVie, Allergan and Acquirer Sub (Filed With SEC on June 25, 2019)
Expenses Reimbursement Agreement, dated as of June 25, 2019, between AbbVie and Allergan (Filed With SEC on June 25, 2019)
Appendix III to the Rule 2.5 Announcement, dated as of June 25, 2019 (Conditions Appendix) (Filed With SEC on June 25, 2019)
Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 3, 2019)
Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (Filed With SEC on May 3, 2019)
Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 3, 2019)
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 3, 2019)
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 3, 2019)